These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 19039961)

  • 21. [Home drug therapy for a patient who rejected use of morphine--management of dyspnea and pain by codeine phosphate].
    Ishiguro T; Kato H; Takahashi M; Abe C; Ishiguro T; Yoshizawa T; Yoshizawa A; Shioya A
    Gan To Kagaku Ryoho; 2000 Dec; 27 Suppl 3():697-9. PubMed ID: 11190325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early conversion from oral morphine to transdermal fentanyl in patients with cancer pain.
    Tani M; Fuku A; Terashita S; Kashiwagi H; Yukawa H; Yamaue H
    Hepatogastroenterology; 2008; 55(86-87):1545-8. PubMed ID: 19102339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Variable prescription of opioids to cancer patients in Norway].
    Olsen AS; Ottesen S
    Tidsskr Nor Laegeforen; 2008 May; 128(11):1271-4. PubMed ID: 18511968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transdermal fentanyl patch for the treatment of chronic intractable pain].
    Ibuki T
    Masui; 2013 Jul; 62(7):784-90. PubMed ID: 23905400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dihydrocodeine: safety concerns.
    Leppert W; Woroń J
    Expert Rev Clin Pharmacol; 2016; 9(1):9-12. PubMed ID: 26479786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addiction to opioids in chronic pain patients: a literature review.
    Højsted J; Sjøgren P
    Eur J Pain; 2007 Jul; 11(5):490-518. PubMed ID: 17070082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L; Manchikanti KN; Pampati V; Cash KA
    Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of opioids on compound action potentials in frog sciatic nerves and their chemical structures.
    Mizuta K; Fujita T; Nakatsuka T; Kumamoto E
    Life Sci; 2008 Aug; 83(5-6):198-207. PubMed ID: 18593589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in psychosocial outcomes in chronic pain patients receiving intrathecal morphine infusions.
    Duse G; Davià G; White PF
    Anesth Analg; 2009 Dec; 109(6):1981-6. PubMed ID: 19923529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An atypical opioid analgesic: tramadol].
    Keskinbora K; Aydinli I
    Agri; 2006 Jan; 18(1):5-19. PubMed ID: 16783663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Case of non-cancer abdominal pain successfully treated by a large amount of oral morphine].
    Baba M; Gomyo I
    Masui; 2011 Feb; 60(2):254-7. PubMed ID: 21384672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transdermal buprenorphine in pain management--experiences from clinical practice: Five case studies.
    Louis F
    Int J Clin Pract; 2006 Oct; 60(10):1330-4. PubMed ID: 16981980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer].
    Oztürk T; Karadibak K; Catal D; Cakan A; Tugsavul F; Cirak K
    Agri; 2008 Jul; 20(3):20-5. PubMed ID: 19085178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
    O'Connor AB; Zwemer FL; Hays DP; Feng C
    Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Introduction of low dose transdermal buprenorphine -- did it influence use of potentially addictive drugs in chronic non-malignant pain patients?
    Skurtveit S; Furu K; Kaasa S; Borchgrevink PC
    Eur J Pain; 2009 Oct; 13(9):949-53. PubMed ID: 19095476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time course of the enhancement and restoration of the analgesic efficacy of codeine and morphine by delta9-tetrahydrocannabinol.
    Williams IJ; Edwards S; Rubo A; Haller VL; Stevens DL; Welch SP
    Eur J Pharmacol; 2006 Jun; 539(1-2):57-63. PubMed ID: 16687136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic opioid treatment of intractable, non-malignant pain.
    Tennant F; Robinson D; Sagherian A; Seecof R
    NIDA Res Monogr; 1988; 81():174-80. PubMed ID: 3136358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended-release opioids for the management of chronic non-malignant pain.
    Sloan P; Babul N
    Expert Opin Drug Deliv; 2006 Jul; 3(4):489-97. PubMed ID: 16822224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term opioid treatment in Behçet's syndrome with intractable abdominal pain--a case report.
    Tseng HC; Wen YR; Chen JY; Lee CL; Wu GJ; Chang Y; Swei SC
    Acta Anaesthesiol Sin; 2002 Sep; 40(3):143-8. PubMed ID: 12434612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
    Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
    J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.